| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| gdc-0068 | rac-alpha serine/threonine-protein kinase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stomach[MeSHID:D013270] Adenocarcinoma[MeSHID:D000230] Malignant neoplasm of prostate[MeSHID:D011471] Malignant Neoplasms[MeSHID:D009369] Colorectal Cancer[MeSHID:D015179] Malignant neoplasm of breast[MeSHID:D001943] |
1.2 | phase 3 | inhibitor |
| gdc-0068 | rac-alpha serine/threonine-protein kinase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stomach[MeSHID:D013270] Adenocarcinoma[MeSHID:D000230] Malignant neoplasm of prostate[MeSHID:D011471] Malignant Neoplasms[MeSHID:D009369] Colorectal Cancer[MeSHID:D015179] Malignant neoplasm of breast[MeSHID:D001943] |
1.2 | phase 3 | unknown |
| click here to return to the previous page | ||||||||